Arcus Biosciences Stock Options

RCUS Stock  USD 17.16  0.26  1.49%   

Arcus Total Stockholder Equity

Total Stockholder Equity

428.29 Million

At this time, Arcus Biosciences' Total Stockholder Equity is comparatively stable compared to the past year.

Arcus Biosciences Corporate Directors

Patrick MachadoIndependent DirectorProfile
Antoni RibasIndependent DirectorProfile
Andrew PerlmanIndependent DirectorProfile
Yasunori KanekoLead Independent DirectorProfile

Additional Tools for Arcus Stock Analysis

When running Arcus Biosciences' price analysis, check to measure Arcus Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcus Biosciences is operating at the current time. Most of Arcus Biosciences' value examination focuses on studying past and present price action to predict the probability of Arcus Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcus Biosciences' price. Additionally, you may evaluate how the addition of Arcus Biosciences to your portfolios can decrease your overall portfolio volatility.